Dr. Myo Min, MD

Dr. Min practices at University of Maryland Upper Chesapeake Medical Center Bel Air in Bel Air, Maryland, part of University of Maryland Medical System.

Dr. Min's NPI, 1740274315, was assigned on September 9, 2005. Dr. Min holds Maryland license D45390.

Dr. Min's primary practice is University of Maryland Upper Chesapeake Medical Center Bel Air, at 500 Upper Chesapeake Drive, Bel Air, MD 21014 in Harford County. The practice phone is (443) 643-3303.

Dr. Min's primary practice is University of Maryland Upper Chesapeake Medical Center Bel Air in Bel Air, Maryland, part of University of Maryland Medical System. Dr. Min is also affiliated with University of Maryland Medical Center. The medical group on file is Agape Physical Therapy. Dmand AI also links Dr. Min to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Min practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Min's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Min is licensed in Maryland.

CMS data shows 98,446 Medicare services from Dr. Min across 26 procedure codes in 2024, for 721 Medicare patients. Medicare paid $2,800,047 for them.

CMS counts 721 Medicare patients who saw Dr. Min in 2024. The largest group is 75 to 84, with 294 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Min's median patient age at 74, with 55% women.

In 2024, Dr. Min wrote 939 Medicare Part D claims for 194 patients. 79% of them were for generic drugs. CMS names the drug for 636 of them, across 26 drugs with 11 or more claims each, at $1,056,891 in total drug cost. In 2023, CMS named 372 claims across 19 drugs.

Dr. Min accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Min as offering telehealth.

Dmand AI links 35 papers to Dr. Min, published from 2011 to 2024. 2016 was the busiest year, with 8. The most frequent topics are Head and Neck Neoplasms, Fluorodeoxyglucose F18 and Positron-Emission Tomography. Dr. Min has published most often in J Med Imaging Radiat Oncol. Dr. Min's most frequent co-authors are Philip D. Bonomi, MD, Tarek A. Chidiac, MD and Thomas M. Cosgriff, MD.

CMS Open Payments shows 46 general payments to Dr. Min from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Bristol-Myers Squibb Company paid the most, $187.